J&J’s ‘remarkable’ Tecvayli data support earlier use in multiple myeloma
J&J’s ‘remarkable’ Tecvayli data support earlier use in multiple myeloma
J&J’s ‘remarkable’ Tecvayli data support earlier use in multiple myeloma
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.